Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli
There is little reported on the efficacy and safety of direct oral anticoagulants (DOACs) in morbid obesity after venous thromboembolism (VTE). In this observational study, patients were followed up after intermediate- or high-risk pulmonary embolism (PE) at the University of Rochester Pulmonary Hyp...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2021-02-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/7/1/00554-2020.full |